Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 25, 2024 6:46pm
RE:RE:RE:RE:Time's Up...
Yes Quentin30.... to each his/her own. So why the consistent dissing? Afraid that you're wrong perhaps?
(68)
•••
Journeytc
X
View Profile
View Bullboard History
Comment by
Journeytc
on Jun 25, 2024 6:43pm
RE:RE:RE:RE:Time's Up...
Quentin i think understand your logic but have a different take. Knocking off critical path tasks matters most. Critical path items define when paleo goes to market and when a take over is
...more
Lahontan Completes Phase Two of 2024 Drilling at Santa Fe
posted Jun 25, 2024 9:00am by
Lahontan Gold Corp.
-
|
"Lahontan is excited to complete the second Phase of our 2024 drilling campaign at Santa Fe. The drilling was completed rapidly and under budget, a tribute to our geologic team and the excellent drill crew. Work on the PEA continues at an accelerating pace, with site visits, scoping studies on capex and operating costs underway. We will continue to update investors as the PEA progresses and when assay results from the 2024 drilling program are received". ...read more
(86)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Jun 25, 2024 6:14pm
RE:RE:RE:Time's Up...
Yup, I downsized my position. Since Matt hadn't mentioned Accelerated Approval wrt to mBC, and since they were only planning to release full results later in the year, I reasoned that a value
...more
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 25, 2024 4:09pm
RE:RE:Time's Up...
Or maybe the unpasteurized milk you shared with him?
(116)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jun 25, 2024 4:04pm
RE:Time's Up...
Maybe Matt drank the Kool-Aid too???
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 25, 2024 3:29pm
RE:RE:Time's Up...
Furthermore Quentin30 you claim to have consolidated your holdings of ONCY to 1/4 of your former position, so why worry about ONCY now.
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 25, 2024 3:23pm
RE:Time's Up...
A new VP of Business Development for ONCY was hired in May. Unfortunately you have been out of touch with everything ONCY.
(86)
•••
Quentin30
X
View Profile
View Bullboard History
Post by
Quentin30
on Jun 25, 2024 2:45pm
Time's Up...
So, by now FDA will have responded to ONCY's Type C Meeting questions. Unlikely that they have exceeded the 75 day goal date. So what does the absence of an announcement from ONCY portend..?
...more
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 25, 2024 1:37pm
RE:RE:RE:How does Accelerated Approval work
June 25, 2024 - Inside the FDA's Accelerated Approval: How it’s extending lives and improving patient care https://www.outsourcing-pharma.com/Headlines/Markets-Regulations/How-does-the
...more
(116)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jun 25, 2024 10:32am
FDA TypeC
Yeah the meeting took place but Matt's got the notes in his office and took the key with him. Shucks looks like no news until he's back, unless someone is going to Seven Mile Beach in
...more
(312)
•••
inthno
X
View Profile
View Bullboard History
Post by
inthno
on Jun 25, 2024 8:47am
New precision platform UK trial
There is a new precision platform trial initiated in the UK. New phase 2 study launched to evaluate triple drug combination in pancreatic cancer The PRIMUS-006
...more
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 24, 2024 4:56pm
RE:RE:How does Accelerated Approval work
Twenty-five patients were enrolled in BMS's Phase 1/2 KRYSTAL-1 study of adagrasib in non-small-cell lung cancer, colorectal cancer, and other solid tumors harboring the KRASG12C
...more
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 24, 2024 4:26pm
RE:How does Accelerated Approval work
June 24, 2024 - Bristrol Myers Squibb's KRAS inhibitor has been granted Accelerated Approval as part of a combination treatment for a subset of colorectal cancer (CRC) patients. The approval is
...more
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 24, 2024 1:46pm
RE:RE:FDA
https://oncolyticsbiotech.com/press_releases/oncolytics-biotech-advances-toward-registration-enabling-trial-for-pelareorep-in-breast-cancer-with-submission-of-type-c-meeting-request-to-fda-2/
(5799)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 24, 2024 1:42pm
RE:FDA
The FDA Type C meeting has taken place with the FDA to provide its formal response by June 25th, if our previous time-line estimates are correct.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
How a truck transportation and logistics company leverages acquisitions and technology
High-grade gold potential in the world’s best mining jurisdiction
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets